Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from antibiotic

How generative AI and physics can help design new antibiotics

By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than eight million deaths around the world every year.

The Conversation

An Oral Antibiotic Pill Proved Just as Effective as IV Treatment for Drug-Resistant UTIs

A clinical trial found oral fosfomycin as effective as IV carbapenem for drug-resistant UTIs from ESBL bacteria. Here's what the finding means for patients and prescribers.

Medical Daily

65 Organizations Petition the FDA to End Routine Antibiotic Use in Healthy Farm Animals Over Human Health Concerns

A 65-organization coalition petitioned the FDA June 2026 to end routine farm antibiotic use. Drug-resistant bacteria from livestock contribute to 35,000 U.S. deaths/year. Here's the issue.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Sore throat or tonsillitis? Symptoms, causes, why infections keep coming back and new treatment options explained

Recurring sore throats and difficulty swallowing might signal tonsillitis, an inflammation of the tonsils. With growing antibiotic resistance, healthcare firms are developing innovative treatments that tackle infection, inflammation, and pain simultaneously. These new bioactive solutions, often plant-based, offer a comprehensive approach to managing this common ailment, urging a shift from…

The Economic Times

At Sid's Farm, a quality-first approach sets the standard.

Sid's Farm is strengthening consumer trust through rigorous daily quality checks and a parent-first approach to dairy production. The company invests over ₹15 lakh every month in antibiotic residue testing while rewarding farmers for maintaining quality standards. Its #HoldUsToIt campaign encourages consumers to question and verify its practices, promoting transparency…

The Economic Times

Scientists infected a 'vagina on a chip' with gonorrhea — then cured it with a new antibiotic found by AI

To sift through 6 million molecules in pursuit of new gonorrhea treatments, researchers trained AI to select the best drug candidate and then tested it in a "vagina on a chip."

LiveScience

Gut Infections Are Spreading: Here's How to Stay Safe

That sudden stomach cramp after lunch. The nausea that won't go away. A day that starts normally but ends with multiple trips to the bathroom. Most of us brush these symptoms off as "something I ate." But as gut infections become more common, especially during the monsoon, ignoring the early…

MyLifeXP

Read news from The Economist, FT, and more,
with one subscription

CDC Confirms One Child Died in Chicago Migrant Shelter Group A Strep Outbreak with 166 Positive Cases

CDC's June 2026 EID report confirms one pediatric death and 166 GAS cases in a Chicago migrant shelter outbreak, highlighting congregate shelter infectious disease risks.

Medical Daily

16 fixed-dose combination drugs banned in India: Check full list here

Fixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics, deeming them therapeutically unjustified. Regulatory reviews found no proven medical benefits for these combinations, prompting immediate prohibition under the Drugs and Cosmetics Act. This move aims to ensure only scientifically validated medicines…

The Economic Times

A new nanotech breakthrough could help heal dangerous wounds antibiotics can’t treat

Scientists are using nanomaterials to heal stubborn wounds that resist antibiotic treatment through a new era of smart wound care. These light-activated therapies target antibiotic-resistant bacteria, destroy protective biofilms, and support faster healing. Research shows up to 99% bacterial reduction in animal studies. The breakthrough could transform treatment for diabetic…

The Economic Times

Rocky Mountain Spotted Fever Can Kill Within Days, Yet 2026 CDC Study Highlights Persistent Delays in Treatment

RMSF kills 5–10% of patients even with treatment. A 2026 CDC study confirms delayed doxycycline is the top predictor of death. What patients and doctors must know this summer.

Medical Daily

Drug-Resistant Gonorrhea Threatens to Make Most Common Bacterial STI in United States Untreatable as CDC Updates Failed Treatment Guidelines

WHO documents a sixfold global rise in azithromycin-resistant gonorrhea, and ceftriaxone-resistant strains are emerging in US cities. With 1.6 million annual US gonorrhea cases, the CDC has updated treatment guidelines in 2026. Here is what the drug resistance crisis means for sexual health in America.

Medical Daily

Suspected human-to-human sexual transmission of dermatophilosis

According to a study, sexual encounters in gay saunas in Lyon may have been responsible for the transmission. Antibiotic treatment led to a rapid improvement in patients’ condition.

Euronews

A New Antibiotic That Defeats Superbugs Just Received FDA Approval for Dangerous Drug-Resistant Urinary Tract Infections

FDA approved Zaynich (cefepime and zidebactam) on May 29, 2026 for complicated urinary tract infections caused by drug-resistant Gram-negative pathogens. ENHANCE-1 Phase 3 trial showed superiority to meropenem at test of cure. Here is how it works and who benefits.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

The Antibiotic Last Line of Defense Against Gonorrhea Just Lost More Ground: WHO Data Shows Sixfold Resistance Rise and U.S. Is Running Out of Options

WHO EGASP data show ceftriaxone resistance in gonorrhea rose more than sixfold globally from 2022 to 2024. Ceftriaxone is the only U.S.-recommended gonorrhea treatment. New pipeline drugs show promise but are not yet approved.

The Economic Times

India’s rising export champion faces a critical credibility test

India's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and diversifying markets, a new threat looms: banned antibiotic residues in shrimp are causing high rejection rates. This quality issue risks undermining the hard-won international trust crucial for sustained growth…

The Guardian - UK

Antibiotics use in livestock could rise by a third in next 15 years, UN report warns

Governments urged to act to prevent potentially disastrous impacts on human resistance to medicines

The Economic Times

Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?

Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for urinary tract infections. The company also reported a strong turnaround in its March quarter results. Revenue and profit saw significant year-on-year growth. Biotech operations were a key driver…

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details

Wockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam, demonstrated superior efficacy over meropenem in a Phase 3 trial. This approval addresses the growing challenge of antimicrobial resistance.

The Independent UK

Scientists create new antibiotic that could help treat drug resistant infections

Antibiotic resistance is responsible for more than a million global deaths a year

The Economic Times

Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibiotic

Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial results and the drug’s potential to treat severe drug-resistant infections boosted investor sentiment, helping the stock extend recent gains despite technically entering overbought territory after a sharp rally.

The Guardian - UK

First Thing: Trump-backed Ken Paxton ousts John Cornyn in Texas primary

Paxton’s win, despite scandals, signals president’s enduring grip over state. Plus, one sex educator on why she doesn’t define sex at all

Medical Daily

Rising Temperatures May Be Fueling Antibiotic Resistance in Salmonella, New Global Study Suggests

As the years go by, the planet continues to get hotter due to global warming—and alongside it emerges one of the most urgent threats in modern medicine: antibiotic resistance.

The Guardian - UK

Climate crisis is accelerating antibiotic resistance across world, study says

Experts say climate change linked to 10% rise in salmonella antibiotic resistance genes between 1940 and 2023

Budget and the Bees

Chronic UTIs, Meet Your Match: New FDA-Approved Fosfomycin Injection Shows 64% Success Against Complicated Infections

For people trapped in the exhausting cycle of chronic urinary tract infections, every new symptom can feel like a setback. Repeated antibiotics, emergency visits, and infections that keep returning can take a serious toll on daily life. Now, a newly FDA-approved fosfomycin injection is offering fresh hope for adults battling…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Chicago Department of Public Health

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.